1. Inicio
  2. Publicaciones
  3. Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration.

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Marina A
  • Francés-Muñoz E
  • Arevalo JF

Grupos

Abstract

The aim of our study was to evaluate the functional and anatomic outcomes of intravitreal ranibizumab for the treatment of symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration.

Datos de la publicación

ISSN/ISSNe:
1177-5483, 1177-5483

Clinical Ophthalmology  DOVE MEDICAL PRESS LTD

Tipo:
Article
Páginas:
161-165
PubMed:
21383943
Factor de Impacto:
0,476 SCImago ℠
Cuartil:
Q3 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • age-related macular degeneration, choroidal neovascularization, drusenoid pigment epithelial detachment, ranibizumab, soft drusen

Compartir